Article
Auditory neuropathy in Brown-Vialetto-Van Laere syndrome due to riboflavin transporter RFVT2 deficiency.
Developmental medicine and child neurology - 1 Aug 2016
Menezes Manoj P, O'Brien Katherine, Hill Mandy, Webster Richard, Antony Jayne, Ouvrier Robert, Birman Catherine, Gardner-Berry Kirsty
Abstract excerpt
AIM: Mutations in the genes encoding the riboflavin transporters RFVT2 and RFVT3 have been identified in Brown-Vialetto-Van Laere syndrome, a neurodegenerative disorder characterized by hearing loss and pontobulbar palsy. Treatment with riboflavin has been shown to benefit individuals with the phenotype of RFVT2 deficiency. Understanding the characteristics of hearing loss in riboflavin transporter deficiency...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
